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ABSTRACT

Understanding the potential toxicity of nanoparticles (NPs) is important to ensure that
these new products do not impose harmful effects to human and environmental health. Paper
I is a literature review in which we discuss characteristics of nanomaterials, with an emphasis
on transition metal oxide nanoparticles that influence cytotoxicity. Identification of those
properties may lead to the design of more efficient and safer nanosized products for various
industrial purposes and provide guidance for assessment of human and environmental health
risk. We then investigate biochemical and molecular mechanisms of cytotoxicity that include
oxidative stress-induced cellular events and alteration of the pathways pertaining to
intracellular calcium homeostasis. All the stresses lead to cell injuries and death.
Furthermore, as exposure to nanoparticles results in deregulation of the cell cycle (i.e.,
interfering with cell proliferation). Paper II is about our original research in which we
evaluated the differential cytotoxicity between nickel oxide (NiO) and nickel hydroxide
Ni(OH)2 in human bronchoalveolar carcinoma (A549) and human hepatocellular carcinoma
(HepG2) cell lines. Cellular viability assays revealed cell line-specific cytotoxicity in which
nickel NPs were only toxic to A549 cells. Time-, concentration-, and particle-specific
viability was observed in A549 cells. NP-induced oxidative stress triggered subsequent
dissipation of mitochondrial membrane potential and induction of caspase-3 enzyme activity.
The subsequent apoptotic events lead to reduction in cell number, though the contribution of
necrosis to cell viability is unknown. In addition to cell death, suppression of cell
proliferation contributes to play an essential role in regulating cell number. Collectively, the
observed cell viability is a function of cell death and suppression of proliferation.
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SECTION

1. INTRODUCTION

Nanoparticles have become increasingly popular in industrial uses for their unique
and useful properties. This increase in use necessitates the need to assess the safety of
these nanoparticles for human and environmental health. Paper one explores some of the
specific properties that have made certain nanoparticles produce more toxic effects than
others. The biochemical and molecular mechanisms of cytotoxicity are then explored,
with an emphasis on the mechanisms of cell cycle alteration. Overall, viability is thought
to be a function of the suppression of proliferation and cell killing. Paper two explores the
specific differential toxicity between NiO and Ni(OH)2. Differences in viability upon
nanoparticle exposure are thought to be cell line-, time-, concentration-, and particledependent. Various mechanisms responsible for viability are investigated including
induction of oxidative stress, dissipation of mitochondrial membrane potential, and
induction of caspase-3 enzymatic activity. Alterations in cell cycle, changes in
proliferation rate, and induction of apoptosis are also delineated. In summary,
cytotoxicity is mediated by oxidative stress-mediated cell death and suppression of
proliferation.
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PAPER
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ABSTRACT

Nanotechnology is an emerging discipline that studies matters at the nanoscale
level. Eventually, the goal is to manipulate matters at the atomic level to serve mankind.
One growing area in nanotechnology is biomedical applications, which involve disease
management and the discovery of basic biological principles. In this review, we discuss
characteristics of nanomaterials, with an emphasis on transition metal oxide nanoparticles
that influence cytotoxicity. Identification of those properties may lead to the design of
more efficient and safer nanosized products for various industrial purposes and provide
guidance for assessment of human and environmental health risk. We then investigate
biochemical and molecular mechanisms of cytotoxicity that include oxidative stressinduced cellular events and alteration of the pathways pertaining to intracellular calcium
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homeostasis. All the stresses lead to cell injuries and death. Furthermore, as exposure to
nanoparticles results in deregulation of the cell cycle (i.e., interfering with cell
proliferation), the change in cell number is a function of cell killing and the suppression
of cell proliferation. Collectively, the review article provides insights into the complexity
of nanotoxicology.
Keywords: nanoparticle; toxicity; physicochemical property; cell proliferation; calcium
homeostasis; oxidative stress

1. INTRODUCTION

Nanoscience is the study of the control of matters at the atomic and molecular
scale. Nanomaterials are materials that have at least one dimension in the range of 1–100
nm. In addition to discovering fundamental principles and advancing knowledge in
nanoscience, nanomaterials have a wide spectrum of applications in our society. Table 1
summarizes the industrial applications of transition metal oxide nanoparticles [1–24].
Some engineered nanomaterials are being used in products with direct exposure to
humans. For example, TiO2 nanoparticles are used in food coloring, cosmetics, skin care
products, and tattoo pigment [1–7]. Fe2O3 nanoparticles are used in the final polish on
metallic jewelry. ZnO nanoparticles are added to many products including cotton fabric,
food packaging, and rubber for its deodorizing and antibacterial properties [18–20].
Engineered nanomaterials also show promise for applications in life science and
biomedical utility such as cellular receptor trafficking, delivery of biologically active
molecules, disease staging and therapeutic planning, and nanoelectronic biosensors
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[25,26]. For instance, nanoparticles incorporated with targeting ligands can enter cancer
cells, where they can release therapeutic drugs [25]. This could decrease the amount of
drug needed to treat a disease (i.e., higher therapeutic efficacy) as well as unwanted side
effects (toxicity). There are more than 3000 nanoparticulate-based commercial
applications. By the end of 2019, its worldwide market is estimated to be $79.8 billion
[27]. As the use of engineered nanomaterials continues to grow exponentially, unintended
and intended exposure may occur, leading to a greater degree of human health risk. The
exposure routes may include inhalation, ingestion, skin, and injection. End-product users,
occupational exposed subjects, and the general public may be at risk of adverse effects.
The use of nanomaterials has significantly grown in the automotive, construction, energy,
biomedical, electronic, textile, chemical, and cosmetic industries [28]. Uncovering the
specific particle surface properties that cause some to be more toxic than others requires a
systematic study focusing on nanoparticles similar in composition (size and morphology).
Therefore, we choose to focus on transition metal oxide nanoparticles widely used in
various industrial applications.

2. CHARACTERISTICS OF NANOPARTICLES THAT INFLUENCE TOXICITY

The physiochemical properties of nanoparticles influence how they interact with
cells and, thus, their overall potential toxicity. Understanding these properties can lead to
the development of safer nanoparticles. Recent studies have begun identifying various
properties that make some nanoparticles more toxic than others. Theoretically, particle
size is likely to contribute to cytotoxicity. Given the same mass, smaller nanoparticles
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have a larger specific surface area (SSA) and thus more available surface area to interact
with cellular components such as nucleic acids, proteins, fatty acids, and carbohydrates.
The smaller size also likely makes it possible to enter the cell, causing cellular damage.
In some nanoparticles, toxicity was found to be a function of both size and SSA. For
instance, the size of anatase TiO2 was shown to correlate with reactive oxygen species
(ROS) production when comparing the amount of ROS production per surface area
within a certain size range [29]. Particles below 10 or above 30 nm produced similar
levels of ROS per surface area. However, there was a dramatic increase in ROS
production per unit surface area in particles increasing from 10 to 30 nm. This
information provides insight regarding the complex relationship between nanoparticle
properties and nanotoxicity. Further studies are needed to determine whether a similar
phenomenon applies to other forms of TiO2 or other particles.
Particle surface charge may affect the cellular uptake of particles as well as how
the particles interact with organelles and biomolecules. Consequently, particle surface
charge influences cytotoxicity. According to mathematical probability and assuming
particles are toxic, high particle uptake (i.e., higher bioavailability) correlates with higher
toxicity. For instance, three similarly sized iron oxide particles with different charges
were found to have differential toxicities on a human hepatoma cell line (BEL-7402)
[30]. Oleic acid-coated Fe3O4, carbon-coated Fe, and Fe3O4 had surface charges of 4.5,
23.7, and 14.5 mV, respectively. The toxicity of the nanoparticles increased with an
increase in surface charge. This suggests that the higher positive charge the nanoparticle
has, the greater electrostatic interactions it has with the cell and, thus, greater endocytic
uptake. Another example is that positively charged ZnO nanoparticles produce more
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Table 1. Applications of transition metal oxide nanoparticles.
Elements
Scandium
(Sc)

Titanium (Ti)
[1–7]

Oxide
Sc2O3

TiO2

V2O5
Vanadium (V)
V2O3
Chromium
(Cr)

Cr2O3
CrO2

Manganese
(Mn)

MnO2

Fe2O3
Iron (Fe)
FeO
Fe3O4
Cobalt (Co)

Co2O3
CoO
NiO

Nickel (Ni)
Ni2O3

Copper (Cu)

CuO

Cu2O
Zinc (Zn)

ZnO

Potential Application
Used in high-temperature systems for its resistance to heat and thermal shock,
electronic ceramics, and glass composition
White pigment, white food coloring, cosmetic and skin care products, thickener,
tattoo pigment and styptic pencils, plastics, semiconductor, solar energy
conversion, solar cells, solid electrolytes, detoxification or remediation of
wastewater; used in resistance-type lambda probes; can be used to cleave
protein that contains the amino acid proline at the site where proline is present,
and as a material in the meristor
Catalyst, a detector material in bolometers and microbolometer arrays for
thermal imaging, and in the manufacture of sulfuric acid, vanadium redox
batteries; preparation of bismuth vanadate ceramics for use in solid oxide fuel
cells [8]
Corundum structure as an abrasive [9], antiferromagnetic with a critical
temperature at 160 K [10] can change in conductivity from metallic to insulating
Protection of silicon surface morphology during deep ion coupled plasma
etching of silica layers; used in paints, inks, and is the precursor to the magnetic
pigment chromium dioxide
Magnetic tape emulsion, data tape applications
Electrochemical capacitor, as a catalyst; used in industrial water treatment
plants
Used as contrast agents in magnetic resonance imaging, in labeling of cancerous
tissues, magnetically controlled transport of pharmaceuticals, localized
thermotherapy, preparation of ferrofluids [11,12], final polish on metallic
jewelry and lenses, as a cosmetic
Tattoo inks
MRI scanning [13], as a catalyst in the Haber process and in the water gas shift
reaction [14], and as a black pigment [15]
Catalyst; for studying the redox and electron transfer properties of
biomolecules; can immobilize protein
Blue colored glazes and enamels, producing cobalt(II) salts
In ceramic structures, materials for temperature or gas sensors, nanowires and
nanofibers, active optical filters, counter electrodes
Electrolyte in nickel plating solutions; an oxygen donor in auto emission
catalysts; forms nickel molybdate, anodizing aluminum, conductive nickel zinc
ferrites; in glass frit for porcelain enamel; thermistors, varistors, cermets, and
resistance heating element
Burning rate catalyst, superconducting materials, thermoelectric materials, catalysts,
sensing materials, glass, ceramics, ceramic resisters, magnetic storage media, gas
sensors, near infrared tilters, photoconductive applications, photothermal
applications, semiconductors, solar energy transformation [16]; can be used to
safely dispose of hazardous materials [17]
Pigment, fungicide, antifouling agent for marine paints, semiconductor
Added to cotton fabric, rubber, food packaging [18–20], cigarettes [21], field
emitters [22], nanorod sensors; Applications in laser diodes and light emitting
diodes (LEDs), a biomimic membrane to immobilize and modify biomolecules
[23]; increased mechanical stress of textile fibers [24]
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cytotoxic effects in A549 cells than negatively charged particles of a similar shape and
size [31]. The phenomenon can be explained, in part, in the context of cellular membrane
composition. Glycosaminoglycans are abundant on the mammalian cell surface. These
molecules are negatively charged and therefore are likely to interact electrostatically with
positively charged nanoparticles [32]. The longer and the more the electrostatic
interactions, the more likely nanoparticles are to be internalized [33]. The same is true in
positively charged nanoparticles interacting with negatively charged DNA, leading to
DNA damage.
Shape also affects levels of toxicity. Amorphous TiO2 was found to generate
more ROS than anatase or rutile of a similar size, with rutile TiO2 causing the least
amount of ROS [29]. It is likely that amorphous TiO2 has more surface defects, and
therefore active sites that are capable of causing ROS. The anatase form of TiO2 was also
significantly more toxic to PC12 cells than the rutile form even though the particles are
similar in size and chemical make-up [34]. Rod-shaped Fe2O3 nanoparticles were found
to produce much higher cytotoxic responses than sphere-shaped Fe2O3 nanoparticles in a
murine macrophage cell line (RAW 264.7), including higher levels of lactate
dehydrogenase (LDH) leakage, inflammatory response, ROS production, and necrosis
[35]. Finally, rod-shaped CeO2 nanoparticles were found to produce more toxic effects in
RAW 264.7 cells than octahedron or cubic particles [36]. Rod-shaped CeO2
nanoparticles produced significant lactate dehydrogenase LDH release and tumor
necrosis factor alpha (TNF) in RAW 264.7 cells, while neither octahedron nor cubic
produced significant responses. Why the physical shape of a nanoparticle influences
cytotoxicity remains to be elucidated.
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Though the above studies and others have contributed to the understanding of
how and why properties of nanoparticles mediate toxicity, a more systematic approach
can even further advance our knowledge in this regard. Our laboratory systematically
selected seven oxides of transition metals (Ti, Cr, Mn, Fe, Ni, Cu, and Zn) from the
fourth period of the periodic table of elements [33]. Four properties of nanomaterials
were tested: particle surface charge, available binding site on particle surface, particle
metal dissolution, and band-gap energy (Figure 1). Particle surface charge was
determined by point-of-zero charge (PZC). We used X-ray photoelectron spectroscopy
(XPS) to measure available binding site on particle surface. Metal ions released from
oxides were analyzed with inductively coupled plasma mass spectrometry (ICP-MS).
Finally, bad-gap energy, which is the energy difference between the top of the valence
band and the bottom of the conduction band in insulators and semiconductors, was
spectroscopically determined. We found that (1) as the atomic number of the element
increases, cytotoxicity increases; and (2) alteration of cell viability is a function of
particle surface charge, available binding site on a particle surface, and particle metal
dissolution, but not of band-gap energy.

3. BIOCHEMICAL AND MOLECULAR MECHANISMS OF CYTOTOXICITY

There have been intensive nanotoxicological studies since the turn of the century
[37–40]. Mechanisms of in vivo nanotoxicity are numerous. They may include, but not
limited to, pulmonary and systemic inflammation, platelet activation, altered heart rate
variability, and vasomotor dysfunction [41]. While in vivo studies provide critical
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Figure 1. Certain physicochemical parameters of transition metal oxide nanomaterials
influence toxicity.

information for risk assessment, in vitro studies help us understand molecular and
biochemical mechanisms of nanotoxicity and give insight into the physicochemical
properties of nanomaterials that contribute to the toxicity. For instance, metal oxide
nanoparticles can elevate the level of oxidative stress (OS) via production of reactive
oxygen species (ROS; e.g., O2•−, OH•, H2O2) in a variety of ways [42]. These highenergy species can attack lipids, nucleic acids, proteins, and other essential biomolecules.
The consequential damage includes damage to mitochondrial structure, depolarization of
mitochondrial membrane, impairment of the electron transport chain, and the activation
of an NADPH-like system [43]. Our laboratory has focused on delineating multiple
biochemical and molecular mechanisms of toxicity induced by exposure to a variety of
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nanoparticles (Figure 2). The nanoparticles tested can elevate cellular OS, which is
manifested in reduced levels of the antioxidants GSH and α-tocopherol [44,45]. This
leads to cellular injury or death via altered signaling pathways. Compromise of cell
membrane integrity is detected via release of LDH from the cell [44,45]. DNA injuries,
including double-strand and single-strand breakages, are identified according to the
comet assay [46]. DNA damage can lead to cell cycle arrest or apoptosis. An oxidative
stress and antioxidant defense microarray assay found alterations in the expression of
four genes that are involved in apoptosis and OS responses: BNIP, PRDX3, PRNP, and
TXRND1 [47]. Membrane depolarization occurs in cells treated with aluminum oxide
(AL2O3) and cerium oxide (CeO2) [48].
In addition to OS, we observed nanoparticle-induced perturbation of intracellular
calcium [Ca2+] in homeostasis, which can be attributed to several molecular actions and
is associated with metabolic and energetic imbalance as well as cellular dysfunction [47]
(Figure 2). Zinc oxide (ZnO) nanoparticles increase [Ca2+]in. The moderation of this
increase by nifedipine suggests that a portion of this increase reflects an influx of
extracellular calcium. Membrane disruption (e.g., by the demonstrated lipid peroxidation,
malondialdehyde MDA) may also play a role in this influx. Nanomaterials disrupt storeoperated calcium entry [49,50]. There exist crosstalks between intracellular [Ca2+]in and
OS, and the increases in both can be reduced by an antioxidant. Finally, while [Ca2+]in
and OS affect the activity of each other, they induce cell death by distinct pathways.
These findings suggest that nanomaterials can trigger cell death via multiple pathways.
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Figure 2. Multiple mechanisms of nanoparticle toxicity contribute to cell cycle
deregulation and cell death. Particles used to delineate the pathways include
Al2O3, SiO2, CeO2, and transition metal oxides.

Studies have shown a decrease in mitochondrial membrane potential (MMP) upon
exposure to ZnO in human bronchial epithelial cells (BEAS-2B) and human alveolar
adenocarcinoma cells (A549) as detected by the MitoTracker® Red CMXRos and JC-1
assay, which indicate risk of early apoptosis [51]. TiO2 causes a loss of MMP in neuronal
cells (PC12) and lung A549 cells [34,52]. Fe3O4 caused a loss of MMP in human
mesenchymal stem cells (hMSCs) [53] and human hepatoma cells (BEL-7402) [30].
TEM images show that ZnO nanoparticles appeared to physically squeeze mitochondrial
cells in HaCaT cells, likely one mechanism of mitochondrial damage [54]. Recent studies
investigated protein deregulation by metal oxide nanoparticles [55]. Using circular
dichroism (CD), Fourier transformed infrared spectrometry (FTIR), fluorescence
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spectroscopy (FS), Raman spectroscopy (RS), and nuclear magnetic resonance (NMR),
the binding of proteins to ZnO, TiO2, SiO2, or FeO nanoparticles can result in minor
conformational changes or protein denaturation, an irreversible binding of proteins to a
nanoparticle [55]. Furthermore, metal ions such as Zn2+ and Cu2+ released from ZnO and
CuO can cause damage to proteins. Metal ions such as copper and zinc can inactivate
certain metalloproteins by dislodging metal ions within them [56]. Another mechanism of
nanotoxicity pertains to cell cycle arrest. Deregulation of cell cycle occurs in cells
exposed to TiO2, Fe2O3, CuO, NiO, ZnO, and Al2O3 [30,34,51–54,57–68] (Table 2).
Cells in cell cycle arrest will either exit cell cycle arrest with potentially compromised
cellular function or undergo apoptosis.

4. MECHANISMS OF CELL CYCLE ARREST

While previous studies have been focusing on alteration of cell viability, recent
studies have demonstrated that a change in cell number in cytotoxicity tests reflects not
just cell killing but also cell cycle arrest, which leads to a suppression of cell
proliferation. Therefore, studies on cell cycle arrest aid a better understanding of the
reduction of viable cells. The suppression of cell proliferation occurs when cells become
arrested in one or more cell cycle phases. Cell growth can become arrested in the G0/G1
phase, the S phase, or the G2/M phase. The phase in which cell growth becomes arrested
is cell-type- and nanoparticle-specific [30,34,51–54,57–68]. Table 2 demonstrates various
changes in cell cycle upon exposure to different nanoparticles in a variety of cell lines.
Certain nanoparticles are likely to cause DNA damage, which may lead to cell cycle
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arrest. Cells arrested in cell cycle will either fix the damage or accumulate too much
damage and undergo apoptosis. While the underlying mechanisms in which cells become
arrested in certain phases of the cell cycle vary, all cells undergoing cell cycle arrest
experience a suppression of proliferation. The degree to which cells experience an
inhibition of proliferation influences cell number from one generation to the next.

4.1. CELL-TYPE-DEPENDENT SUPPRESSION OF THE CELL CYCLE
Exposure of nickel oxide nanoparticle (NiONP) resulted in a significant increase
in the G0/G1 in the BEAS-2B cell line but a significant decrease of the G0/G1 phase in the
A549 cell line [57]. Consequently, exposure to NiONP resulted in a significant decrease
in the G2/M in the BEAS-2B cell line and a significant increase of the G2/M phase in the
A549 cell line. However, the S phase was only significantly affected in the BEAS-2B cell
line. Furthermore, exposure to ZnO caused an increase in the population of cells in the
G2/M phase in A549 cells but did not affect cell cycle distribution in BEAS-2B cells.
[51]. These studies demonstrate that cell cycle arrest is cell-type-specific, evidence of
cellular stress activating different response pathways in different cell types.

4.2. NANOPARTICLE DEPENDENT SUPPRESSION OF CELL CYCLE
Cell cycle arrest also differs based on the type of nanoparticle. It appears that cell
cycle arrest occurs most commonly in the G2/M phase. However, arrest can also happen
in the G0/G1 and S phases. In BEAS-2B cells, exposure to NiO caused cells to become
arrested in the G0/G1 phase, while exposure to ZnO and Fe2O3 did not affect the cell
cycle [51,57]. ZnO and CuO exposure resulted in arrest in the G2/M phase, while TiO2
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exposure resulted in arrest in the S phase in HaCaT cells [54,58,62]. Al2O3 and Fe3O4
caused an increase in the sub-G0 phase of human mesenchymal stem cells (hMSFs)
[53,63]. A549 cells became arrested in the G2/M phase upon exposure to CuO, NiO, and
ZnO, but experience no change in cell cycle upon exposure to Fe2O3 [51,57,59,60]. One
study found that TiO2 exposure caused A549 cells to become arrested in the G0/G1
phase, while two other studies found that exposure caused arrest in the G2/M phase
[52,60,61]. This could be due to differences in TiO2’s size or other properties.
Collectively, cell cycle alteration is a complex matter involving properties of both cells
and particles.

4.3. CHANGES IN GENE EXPRESSION UNDERLIE THE MECHANISMS OF
CELL CYCLE ARREST
Study of gene responses upon nanoparticle exposure can further enhance our
understanding of the biological pathways in which nanoparticles induce cell cycle arrest.
Cell cycle progression is regulated by a variety of growth factors that promote transition
through various phases as well as inhibitors that prevent or decelerate transition.
Exposure to nanoparticles can result in a wide array of gene expression deregulation
pertaining to the cell cycle. For instance, exposure to CuO nanoparticles causes
downregulation of 90 cell cycle genes [59]. Nanoparticle exposure can affect different
genes in different cell lines upon exposure to the same nanoparticle. There is a cell-typespecific difference in the regulation of the cell cycle between a normal intestinal cell line
NCM460 and two cancerous intestinal cell lines, DLD-1 and SW480 [69]. ZnO exposure
induced the p53 pathway in NCM460 cells but not DLD-1 or SW480 cells. The mutated
p53 function in the cancerous cell lines might have contributed to the observed
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difference. NCM460, DLD-1, and SW480 cell lines experienced an increase in
checkpoint kinase 1 (Chk-1), leading to cell cycle arrest. Not all cancerous cell lines are
incapable of inducing the p53 pathway. For instance, cancerous A549 cells experienced
an increase in the expression of p53 upon exposure to TiO2 [61]. TiO2 was found to
induce double-strand breaks and a downregulation of cyclin B1 (a protein involved in
mitosis) in A549 cells, leading to cell cycle arrest in the G2/M phase [61]. CuO exposure
causes the downregulation of various genes that allow cells to progress through the cycle
at a couple of checkpoints in A549 cells [59]. Exposure of CuO downregulates
proliferating cell nuclear antigen (PCNA, involved in proliferation), cell-division cycle
protein (CDC2), and cyclin B1 (CCNB1, involved in G2 to M transition) [59]. ZnO
exposure causes DNA damage and the downregulation of cyclin B1 and cyclin-dependent
kinase 1 (CDK1) in human immortal keratinocyte cells (HaCaT), causing G2 arrest.
PCNA was also downregulated [54]. Further studies are needed to demonstrate what
genes cause cells to become arrested in the S or G0/G1 phase of the cell cycle. A
systematic study looking at the gene responses after exposing a cell to different
nanoparticles that lead to phase-specific changes in the cell cycle could provide evidence
of how the characteristics of nanoparticles induce specific changes. It is possible for cells
in cell cycle arrest to recover and continue proliferating upon the removal of
nanoparticles. A549 cells whose proliferation is halted by CuO exposure could start
proliferating again if cultured in a fresh medium. Reduction of stress can also allow cells
to recover from cell cycle arrest. For instance, ZnO nanoparticle exposure induces G2/M
arrest in intestinal cell lines and the addition of antioxidant N-acetylcysteine can reverse
cell cycle arrest by approximately 50–70% [69].
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5. CYTOTOXICITY IS A FUNCTION OF CELL KILLING AND SUPPRESSION
OF PROLIFERATION

Numerous mechanisms may involve toxicity induced by exposure to nanoparticles.
Altered signaling pathways perturb cellular homeostasis leading to cellular injuries.
Nanotoxicity could lead to suppression of proliferation (via cell cycle arrest). When cells
cannot overcome the stress and fix the damage, they are destined to death (apoptosis or
necrosis). While the mechanisms that determine which cell cycle phase could become
arrested are multiple, the consequential suppression of proliferation affects the cell
number from one generation of cells to the next. Using the tritiated thymidine
incorporation assay, we recently demonstrated that seven transition metal oxide
nanoparticles can differentially suppress cell proliferation [70] (unpublished data).
Assuming the doubling time of a cell line is 24 h and the rate of doubling time of cells is
not altered, upon exposure to nanoparticles over a period of 24 h, the estimated number
of cells in the second generation is expected to be as follows:

Cell # in Generation
= 2(Proliferating cells) + non proliferating cells – dead cells

Future studies should weigh the contribution of these two independent variables to the
alteration in cell number.
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6. CONCLUSIONS

Nanotoxicology emerged approximately at the turn of the century. Numerous
studies have been conducted to better understand the impact nanomaterials have on
environmental and human health and help us move toward making safer materials. In
vitro studies are essential to identify biochemical and molecular mechanisms of
cytotoxicity as the complexities of toxicokinetics and toxicodynamics typically observed
in animal studies do not exist. In vitro studies provide insight to hazard identification
which can lead to further studies on animal subjects. They are also the first step in
identifying occupational risk assessment. Cumulative studies could potentially lead to a
characterization model that allows workers to become aware of the potential risks of
nanoparticle exposure. Preliminary data from in vitro experiments can potentially provide
a precautionary risk management system in which workers are educated on the
nanoparticles that have been shown to produce toxic and carcinogenic effects in in vitro
experiments [28]. Properties of nanoparticles that contribute to cytotoxicity include, but
are not limited to, surface, particle size, particle morphology, and dissolution of ions. As
oxidative stress is elevated, and intracellular calcium homeostasis is perturbed due to
exposure to nanoparticles, subsequent actions lead to cell injury and death, and
deregulation of the cell cycle. The change in cell number is a function of cell killing and
the suppression of proliferation. Deregulation of the cell cycle could result in cell death,
non-proliferation, or recovery (upon removal of nanoparticles). Although the scientific
community has made considerable strides in understanding nanotoxicity in the recent
past, the future research needed to decipher nanotoxicity remain significant. For instance,
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what are the properties of the nanoparticle that induce oxidative stress? How do
nanoparticles interact, physically and chemically, with biomolecules such as nucleic
acids, proteins, and lipids leading to alteration of gene expression? What is the basic
scientific principle that dictates the shape-dependent cytotoxicity? Last but not least,
quantification of cellular uptake of nanoparticles using single-particle ICP-MS may help
with (1) the correlation of dose–effect and (2) the contribution of dissolved ions to
cytotoxicity. As more information is gathered, it may be possible to apply the concept of
quantitative structure and activity relationship (QSAR) to systematically delineate the
cause–effect relationship. This could further improve the safety of the nanomaterial
worker.
Conflicts of Interest: The authors declare no conflict of interest.
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II. DIFFERENTIAL CYTOTOXICITY OF NiO AND Ni(OH)2
NANOPARTICLES IS MEDIATED BY OXIDATIVE STRESS-INDUCED
CELL DEATH AND SUPPRESSION OF CELL PROLIFERATION

ABSTRACT

The use of nanomaterial-based products continues to grow with advancing
technology. Understanding the potential toxicity of nanoparticles (NPs) is important to
ensure that these new products do not impose harmful effects to human and
environmental health. In this project, we evaluated the differential cytotoxicity between
nickel oxide (NiO) and nickel hydroxide Ni(OH)2 in human bronchoalveolar carcinoma
(A549) and human hepatocellular carcinoma (HepG2) cell lines. The sulforhodamine B
assay was used measure cellular viability after 10, 25, 50, 75, and 100 µg/mL of NiO and
Ni(OH)2 NPs for 24h and 48h. Cellular viability assays revealed cell line-specific
cytotoxicity in which nickel NPs were toxic to A549 cells but relatively nontoxic to
HepG2 cells. Time-, concentration-, and particle-specific viability was observed in A549
cells. NP-induced oxidative stress triggered subsequent dissipation of mitochondrial
membrane potential and induction of caspase-3 enzyme activity. The subsequent
apoptotic events lead to reduction in cell number, though the contribution of necrosis to
cell viability is unknown. In addition to cell death, suppression of cell proliferation
contributes to play an essential role in regulating cell number. Elevated OS had a strong
correlation with viability. Collectively, the observed cell viability is a function of cell
death and suppression of proliferation.
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1. INTRODUCTION

Nanomaterials have become increasingly popular in the production of a wide
range of products including cosmetics [1], pharmaceuticals [2], medical research [3],
semiconductor fabrication [4], food [5], electronic manufacturing [6], and many other
products. Nanomaterial-based products are estimated to reach $79.8 billion in the global
market by the year 2019 [7]. The increase in the use of nanoparticles (NPs) may increase
the risk of human exposure via air, water, and food. Workers in various industries are at
higher risk of exposure to NPs via inhalation [8]. While some NPs are relatively
harmless, others have been shown to produce moderate to severe toxic effects In vitro
studies have demonstrated that NPs can become internalized within the cells where they
can cause damage [9-13]. Such damages include increase of reactive oxidative stress,
mitochondrial dysfunction, severe damage of DNA, cell cycle arrest, induction of
apoptosis and increase in necrosis [14]. These changes within the cell affect overall cell
viability.
Toxicity depends on physicochemical properties of NPs [15]. For example,
morphology of TiO2 NPs affects cytotoxicity. The amorphous form of TiO2 generated
the most reactive oxygen species (ROS) followed by anatase and then rutile [16]. Rodshaped CeO2 produced toxic responses in RAW 264.7 cells while the octahedron and
cubic elicited little responses [17]. Surface charge may also influence toxicity, with
positively charged ZnO producing a higher degree of toxicity than negatively charged
particles in A549 cells [18]. Three iron NPs (Fe3O4, OA- Fe3O4, and C-Fe) with
different positive charges were found to produce toxic responses in A549 cells that
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positively correlated with the charge [19]. Dissolution rate, relative available binding
sites on particle surface, and particle surface charge of various transition metal oxides
correlated with toxicity in A549 cells [20]. It is important to note that the mechanisms of
toxicity of NPs are not always, but can be, cell line-dependent [9, 21]. For instance, NiO
NPs arrest BEAS-2B cells in the G1 phase while arrest of A549 cells occurs in the G2/M
phase [21]. Furthermore, NiO NPs induce a higher rate of apoptosis in BEAS-2B cells
than A549 cells. Additionally, ZnO exposure induces cell cycle alterations in A549 cells
but not BEAS-2B cells [9].
Nickle NPs may impose risk on human health as they are widely used in various
industries. NiO NPs are used in coloring agents for enamels, in nanowires, in automotive
rear-view mirrors, and more products [22]. Ni(OH)2 NPs are used in rechargeable battery
electrodes, nickel cadmium batteries, and nickel metal hydride batteries [23]. Toxic
responses upon exposure to NiO and Ni(OH)2 NPs have been characterized in both in
vivo and in vitro settings. Exposure to NiO or Ni(OH)2 NPs induces inflammation in the
lungs of rats [24, 25]. NiO was found to induce ROS and lipid peroxidation in A549 cells
[26]. Exposure of NiO NPs induces oxidative stress, apoptosis, reduction in viability in
breast cancer cell line MCF-7 and the human airway epithelial cell line HEp-2 [27].
Exposure to particulate and soluble nickel compounds led to differential toxicity in AS52
cells [28].
There are no studies comparing the difference in cellular toxicity upon exposure
of NiO and Ni(OH)2 NPs in A549 cells. Further, there have been no studies on the role
of suppression of cell proliferation induced by NPs. Our preliminary data suggest that
Ni(OH)2 NPs decrease viability more significantly than NiO NPs. We thus
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hypothesize that 1) cytotoxicity of NiO and Ni(OH)2 NPs is cell line-, particle-, time-,
and dose-dependent, 2) cytotoxicity is mediated by oxidative stress and subsequent
cellular events including modulation of mitochondrial membrane potential and caspase-3
enzyme activity, and 3) exposure to NiO and Ni(OH)2 NPs alters cell cycle leading to
suppression of cell proliferation. Our specific aims are to: 1) demonstrate that
cytotoxicity is cell line-, particle-, time- and dose- dependent, 2) measure the differences
in various biochemical responses upon NiO or Ni(OH)2 exposure, and 3) investigate that
cell viability is a function of cell killing and inhibition of cell proliferation. To achieve
our goals, we measured cell viability in a liver cell line (HepG2) and a lung cell line
(A549) upon NiO or Ni(OH)2 exposure. We then delineated the mechanism of action of
toxicity in the context of oxidative stress-mediated cellular injuries, including
mitochondrial membrane potential, caspase-3 activity, apoptosis, cell cycle, and
proliferation.

2. MATERIALS AND METHODS

2.1. SOURCES OF MATERIALS
NiO was purchased from Nanostructured and Amorphous Materials (Los Alamos,
New Mexico, USA). Ni(OH)2 was purchased from US Research Nanomaterials
(Houston, Texas, USA). Human bronchoalveolar carcinoma-derived (A549) cells and
human liver hepatocellular carcinoma (HepG2) cells were acquired from American
Tissue Culture Collection (Manassas, VA, USA). H2DCFDA and propidium iodide were
obtained from Fisher Scientific (St. Peters, MO, USA). The JC-1 Mitochondrial
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Membrane Potential Detection Kit and sulforhodimine B were purchased from Biotium
(Freemont, CA, USA). Ac-DEVD-pNA was obtained from Anaspec (Fremont, CA,
USA). Annexin V-FITC and 7-aminoactinomycin D (7-AAD) were acquired from BD
Biosciences (San Jose, CA, USA). Tritiated thymidine was purchased from Perkin-Elmer
(Downers Grove, IL, USA). Other chemicals used for experiments were of the highest
purity that they could be obtained.

2.2. STORAGE AND CHARACTERIZATION OF NANOPARTICLES
NPs were stored in an amber desiccator under a pure nitrogen atmosphere to
protect them from moisture, oxidation, and UV damage. The instrumentation and
protocols used to characterize NPs followed our previous publications [29]. Specific
surface area (SSA) and shape of NPs in non-aqueous conditions were measured by
Brunauer-Emmett-Teller (BET) and X-Ray Diffraction (XRD), respectively. Size, shape,
surface charge, and relative available surface binding sites of NPs in aqueous conditions
were measured by transition electron microscopy (TEM) and point of zero charge (PZC).

2.3. CELL CULTURE AND NANOPARTICLE TREATMENT
2.3.1. Cell Line Maintenance. A549 cells were maintained in Hams F-12
modified medium supplemented with 10% fetal clone serum and 1%
penicillin/streptomycin. HepG2 cells were maintained in Eagle’s minimum essential
medium supplemented with 10% fetal clone serum and 1% penicillin/streptomycin. Both
cell lines were grown in 10 cm tissue culture dishes at 37°C in a 5% CO2 humidified
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incubator. All cells were grown to a confluence of ca. 70-80% before the next passage.
Appropriate numbers of cells were seeded for various experiments (Appendix A1).
2.3.2. Exposure of Cells to Nanoparticles. NPs were dispersed evenly in cell
culture medium before cells exposure in the following way. The NPs were weighed
using an analytical balance. One milliliter of medium was added to create a final
concentration of 1 mg NP per 1 mL medium. The samples were then sealed with parafilm
and sonicated for 3 min to break up aggregates. The suspension was vortexed to achieve
a homogenous mixture before adding to cells. Experiments performed using a 24 well
plate were performed as a triplicate, and the average of each group was taken for each
individual experiment.

2.4. CELL VIABILITY
Cell viability was measured using the sulforhodamine B assay (SRB). Upon
termination of experiments, cell medium was discarded from the cells. The cells were
fixed with cold 10% trichloroacetic acid (TCA) for 1h at 4oC. The cells were then
washed three times with distilled water and then allowed to dry completely. Cells were
incubated with 0.5 mL SRB (0.2% in 1% acetic acid) for 30 min at room temperature.
The cells were then washed with 1 mL of 1% acetic acid for 20 min on a rocker three
times to eliminate excess dye. A Q-tip was used to remove excess solutions stuck to the
sides of the wells. Acetic acid was removed followed by addition of 400 µL of cold 10
mM Tris hydrochloride solution to each well for 20 min. Aliquots of 250 μL each were
transferred onto a 96-well plate. Absorbance was measured at 510 nm using a microplate
reader (FLOURstar, BMG Labtechnologies, Durham, NC, USA). Cell viability of
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treatment groups were calculated based on the percent absorbance relative to the control
group.

2.5. REACTIVE OXIDATIVE SPECIES
Reactive oxidative species was measured with 2',7'-dichlorodihydrofluorescein
diacetate (H2DCFDA). Upon entrance of the cell, H2DCFDA is deacetylated by esterases
into a non-fluorescent compound. When H2DCFDA is oxidized by reactive oxidative
species, it is converted to the highly fluorescent compound 2’,7’-dichlorofluorescein
(DCF) that can be detected by fluorescence spectroscopy. Cells were exposed to a serious
of concentrations of NPs (0, 10, 25, 50, 75, or 100 µg/mL) for 24h or 48h. For positive
control, cells were incubated with 400 µM tert-butyl hydroperoxide (t-BHP) at 37°C for
1h before termination of the experiment. Upon termination of the dosing period the media
was removed from the cells followed by a wash with PBS once. Eighty microliters of
H2DCFDA was added to each well for 1h. Cells were then washed with PBS three times
followed by addition of 100 µL of PBS. Fluorescence was measured using a microplate
reader (FLOURstar, BMG Labtechnologies, Durham, NC, USA) with excitation at 485
and emission at 510. The florescence intensity of cells in experimental plates will be
divided by the fluorescence intensity in control cells to determine the percent increase in
ROS.

2.6. MITOCHONDRIAL MEMBRANE POTENTIAL
Mitochondrial membrane potential was determined with microscopy using the JC1 Mitochondrial Membrane Potential (MMP) Detection Kit. JC-1 in the cytosol exist as
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green fluorescing monomers. Healthy mitochondria have a high negative potential that
result in a high influx of cationic JC-1, increasing the JC-1 concentration by as high as
1000x. High concentrations of JC-1 form aggregates that fluoresce red. Unhealthy
mitochondria have a lower negative potential and will therefore intake less JC-1. The JC1 will remain in the cytosol as green fluorescing monomers.
Cells were exposed to a serious of concentrations of nanoparticles (0, 10, or 100
µg/mL) for 12h or 24h. Upon termination of experiments, the plates were incubated with
JC-1 working solution at 37° C for 15 minutes. Each plate was then washed with 1 mL of
PBS followed by addition of 1 mL of PBS before fluorescence detection under a
fluorescence microscope. Rhodamine was observed with a Texas Red filter (ex/em
590/610 nm) while fluorescein with a FITC filter (ex/em 490/520 nm).

2.7. CASPASE-3 ACTIVITY
Caspase-3 enzymatic activity was measured using Ac-DEVD-pNA as a substrate.
Cells were exposed to a serious of concentrations of NPs (0, 10, 25, 50, 75, or 100
µg/mL) for 24h or 48h. Upon termination of experiments, cells were washed with 0.5
mL of PBS. Lysis buffer (50mM Tris-HCl, 1.5 mL of 5 M NaCl, 0.25 g sodium
deoxycholate, 1 mM EDTA, 0.5 mL Triton-100, 50 mL DI water) was added. Cells were
scratched off the bottom, then resuspend in the lysis buffer and incubated in 4°C for 10
min. Samples were centrifuged at 15,000 g for 20 min at 4°C. Reaction buffer (20%
glycerol, 0.5 mM EDTA, 5 mM dithiothreitol, 100 mM HEPES, pH 7.5) was added to
cell lysate that contain 20 µg of cell protein in each well to make a total volume 198 µL
per well. Then, 2 µl chromogenic Ac-DEVD-pNA substrate was added to each well.
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Samples were incubated at 37° for 6h. Absorbance of enzyme-catalyzed release of pnitroanilide is measured at 405 nm with a microplate.

2.8. CELL CYCLE
Alteration of cell cycle due to exposure NPs was measured with flow cytometry
using propidium iodide (PI). Cells were exposed to a series of concentrations of NPs (0,
10, 25, 50, 75, or 100 µg/mL) for 24h or 48h. Upon termination of experiments, the cells
were washed with PBS, harvested using trypsin, and centrifuged. The cell pellet was then
re-suspended in 1 mL of PBS followed by the addition of 3 mL of cold absolute methanol
to fix the cells. The cells were placed in the refrigerator for at least 24h to allow complete
fixation. After fixation, the cells were centrifuged and then washed twice with 1x PBS
(centrifuging in between each wash). The cells were then suspended in a PI staining
solution (PI and ribonuclease A in 1x PBS) for 15 min in the dark. One mL of PBS was
added to each sample before centrifuging. The supernatant was removed, and cells were
resuspended in 250 µL PBS. The stained samples were then plated into a 96 well plate
and analyzed with Cell Lab Quanta SC MPL flow cytometer. FCS Express 6 software
was used to determine changes in cell cycle phase. The total number of cells in each
phase of the cell cycle (G0/G1, S and G2/M) was totaled and the percentage in each phase
was calculated.

2.9. APOPTOSIS
Apoptosis was measured with flow cytometry using annexin V-FITC and 7aminoactinomycin D (7-AAD). Cells were exposed to a series of concentrations of NPs
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(0, 10, 25, 50, 75, or 100 µg/mL) for 24h or 48h. Upon termination of experiments, cells
were washed with PBS, harvested with trypsin, and centrifuged. The supernatant was
then discarded, and 1 mL of ice cold PBS was added to resuspend the pellet followed by
centrifugation. After centrifugation, the supernatant was removed. The cells were
resuspended in 100 µL of 1x concentrated annexin V binding buffer, 5 µL of annexin VFITC and 5 µL of 7-AAD. The cells were incubated for 15 min in the dark. Another 200
µL of Annexin V binding buffer was then added to each tube and 150 µL of this
cell/dye/binding buffer mixture was transferred to a 96 well microplate for flow
cytometry analysis. Early and late apoptotic cells were added to determine the total
percentage of apoptotic cells.

2.10. PROLIFERATION
Proliferation was determined with the tritiated thymidine (3H-thymidine)
incorporation assay. Cells were exposed to a series of concentrations of NPs (0, 10, 25,
50, 75, or 100 µg/mL) and 3H-thymidine simultaneously for 24h or 48h. Upon
termination of the experiment, cells were washed twice with ice cold 1x PBS. The cells
were then fixed in 0.5 mL ice cold 10% TCA for 5 min on ice. TCA fixation was
repeated once. Cells were brought to room temperature and lysed using a roomtemperature 1 M NaOH solution for 5 min. The solution was neutralized by adding an
equal amount of 1 M HCl. The lysed cell solution was thoroughly mixed by pipetting up
and down and then transferred to scintillation vials with Econo-Safe scintillation
counting fluid (Research Products International, Mt Prospect, IL, USA). These vials were
then subject to scintillation counting using a Beckman liquid scintillation counter LS6500
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(Beckman-Coulter, Fullerton, CA, USA). The total count of radioactivity was divided by
the radioactivity from the control cells to determine the percentage of proliferating cells
compared to unexposed cells.

2.11. STATISTICAL ANALYSIS AND FIGURES
Three to five independent experiments were conducted. Each individual
experiment was run as a triplicate. Statistical analysis was performed in Minitab 18. Data
sets are presented as means ± standard deviation, with the number of individual
experiments defined as N. A one-way t-test was used to compare experimental groups to
the control groups (µ>control or µ<control depending on the experimental hypothesis).
One-way analysis of variance (ANOVA) with Tukey’s post hoc pairwise comparison was
used to determine significant differences among each treatment group. One-way ANOVA
with Dunnett post hoc pairwise comparison was used to determine significant differences
against the control group. Significance was set at p<0.05. All figures were produced
using GraphPad Prism 7.

3. RESULTS

3.1. PHYSIOCOCHEMICAL PROPERTIES OF NIO AND Ni(OH)2
The approximate physical sizes (APS) of NiO and Ni(OH)2 were 16 ± 4 nm and
15 ± 5 nm, respectively (Table 1, Fig. 1). The specific surface area (SSA) of NiO was
73.5 m2/g and the SSA of Ni(OH)2 was 103.2 m2/g (Table 1). The morphology
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Table 1. Physical characteristics of NiO and Ni(OH)2 NPs
APS* (nm)
SSA** (m2/g)
Shape

NiO
16.± 4.8
73.5
Cubic

Ni(OH)2
15. ± 4.9
103.2
Hexagonal/rod

*APS denotes approximate physical size; length of the
cubic NiO and length of the rod of Ni(OH)2
**SSA denotes specific surface area

determined by X-ray Diffraction (XRD) analysis was cubic (NiO) or a hexagonal/rod
shape (Ni(OH)2) (Fig. 1). The PZC was 8.7 for NiO and 7.9 for Ni(OH)2 (Fig. 2).

3.2. CELL VIABILITY
Two nickel NPs (NiO and Ni(OH)2) were chosen for comparative toxicity in the
context of cell viability, oxidative stress-induced cellular injuries, and suppression of cell
proliferation. Results from cell viability of A549 and HepG2 revealed cell-line
dependent cytotoxicity (Fig. 3A). NiO and Ni(OH)2 did not produce as prominent
cytotoxic effects in HepG2 cells as in A549 cells. There was no significant change in
viability upon exposure to NiO for 24h or 48h or to Ni(OH)2 for 24h in HepG2 cells
(N=3, p<0.05). HepG2 exposure to Ni(OH)2 at 75 and 100 µg/mL for 48h resulted in a
significant decrease in viability to 71.2% and 72.6%, respectively. On the other hand,
exposure to NiO or Ni(OH)2 caused a significant reduction of toxicity in all experimental
groups in A549 cells, which was not observed in HepG2 cells. At 24h, the lowest tested
concentration (10 µg/mL) reduced viability to 84.3% and 81.3% when A549 cells were
exposed to NiO or Ni(OH)2, respectively (N-3, p<0.05) (Fig. 3B). These percentages
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(A)

(B)

(C)

(D)

Figure 1. Morphology and crystalline structure. Morphology of NiO (A) and Ni(OH)2 (B)
NPs from transmission electron microscopy. Crystalline structure of NiO (C) and
Ni(OH)2 (D) NPs from XRD analysis. NiO has a cubic shape. Ni(OH)2 possesses a long
rod shape with a hexagonal top and bottom.
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Figure 2. Point of zero charge (PZC) analysis of NiO and Ni(OH)2. Results indicate that
the PZCs of NiO and Ni(OH)2 are 8.7 and 7.9.

were further reduced at 48h. At 48h, the highest tested concentration (100 µg/mL),
reduced viability to 27.0% and 11.1% when A549 cells were exposed to NiO or Ni(OH)2,
respectively (N=3, p<0.05) (Fig. 3C). Viability of A549 cells was NP-, time-, and
concentration- specific (Fig. 3B-D). A NP-specific viability was observed at both 24h and
48h. Ni(OH)2 is more toxic than NiO at 25 µg/mL and above at 24h (N=3, p<0.05). At
100 µg/mL, Ni(OH)2 reduced viability to 57.8% while NiO reduced viability to 39.2%
(Fig. 3B). Ni(OH)2 µg/mL is more toxic than NiO at 50 µg/mL and above at 48h (N=3,
p<0.05). At 50 µg/mL, viability was reduced to 45.4% upon NiO exposure and to 32.9%
upon Ni(OH)2 exposure (Fig. 3C). Time-specific effects were manifested in an exposure
duration of 48h. Both NiO and Ni(OH)2 were more toxic at 48h than at 24h at all tested
concentrations (N=3, p<0.05). Exposure to NiO reduced viability to 57.8% (24h) and
27.0% (48h) at 100 µg/mL. Ni(OH)2 exposure reduced viability to 39.1%
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(B)

(C)

(D)

(E)

Figure 3. Cell viability upon exposure to NiO or Ni(OH)2. (A) Viability of Hep-G2 cells
upon exposure to NiO or Ni(OH)2 at the time periods of 24h and 48h. Particle-dependent
viability of NiO vs. Ni(OH)2 is seen at the time periods of (B) 24h and (C) 48h. Time
dependent-viability of 24h vs. 48h is shown for the particles (D) NiO and (E) Ni(OH)2.
N=3, *p<0.05 vs control using a one-way ANOVA test followed by Tukey post hoc test.
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(24h) and 11.1% (48h) at 100 µg/mL. Overall, reduction in viability occurred in a NP
concentration-dependent manner. Importantly, cells tested at 48h had a steeper decrease
in viability than cells exposed to the same NP for 24h. Due to the significant differences
in toxicity upon NiO or Ni(OH)2 exposure, A549 cells were subject to subsequent
mechanistic studies of cytotoxicity.

3.3. OXIDATIVE STRESS
3.3.1. Elevation of Oxidative Stress (OS). Oxidative stress was measured upon
NiO or Ni(OH)2 exposure in A549 cells to determine its role in the decrease of cell
viability. At 24h, both NPs increased OS at 25 µg/mL and above, with Ni(OH)2
producing a steeper increase of OS (N=4, p<0.05). At 100 µg/mL, OS was elevated up to
1.7 and 2.5-fold by NiO and Ni(OH)2, respectively. A strong positive linear correlation
existed between OS and viability for both NiO (R2 = 0.93) and Ni(OH)2 (R2 = 0.98) at
24h (Appendix A2). At 48h, NiO significantly increased OS at 25 µg/mL and above
while Ni(OH)2 increased ROS at all tested concentrations (N=4, p<0.05). Distinctively,
NiO induced OS at a much steeper increase than Ni(OH)2 at 48h (Fig, 4). OS was
increased by up to 4.3 and 3.3 times in NiO and Ni(OH)2, respectively. Regardless of the
fold increase, a strong positive linear correlation existed between OS and viability for
both NiO (R2 = 0.95) and Ni(OH)2 (R2 = 0.99) at 48h (Appendix A2).
3.3.2. Perturbation of Mitochondrial Membrane Potential (MMP). The
dissipation of mitochondrial membrane potential was observed to determine its role in
loss of viability in A549 cells upon exposure to NiO or Ni(OH)2. In the untreated control
cells, an abundance of red color is indicative of healthy mitochondria. Cells treated with
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Figure 4. ROS produced in A549 cells upon exposure to NiO or Ni(OH)2. *p<0.05
vs control using a one-way t- test. **p<0.01. ***p<0.001. N=4.

Ni(OH)2 or NiO experience OS and have a noticeable decrease in healthy mitochondria
(Fig 5). Exposure to Ni(OH)2 appears to decrease the abundance of healthy mitochondria
more than exposure to NiO. This is likely a result of a higher OS production upon
exposure to Ni(OH)2, inducing a greater dissipation in MMP (Fig. 4). There seems to be
little to no difference between 12h and 24h in NiO or Ni(OH)2 exposed cells.
3.3.3. Elevation of Caspase-3 Enzymatic Activity. Caspase-3 enzymatic
activity was measured to determine the role of programed cell death in A549 cells upon
exposure to NiO or Ni(OH)2 (Fig. 6). Exposure to NiO significantly increased caspase-3
activity in all groups except for 10 µg/mL at 24h and 48h (N=3, p<0.05). Caspase-3
enzymatic activity reached its highest level in NiO exposed cells at 75 µg/mL (1.40 fold)
and 100 µg/mL (1.85 fold) after 24h and 48h exposure, respectively. Ni(OH)2 also
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significantly increased caspase-3 activity in all exposed groups at 24h and 48h (N=3,
p<0.05).

Control

10 µg/mL

100 µg/mL

NiO
12h

NiO
24h

Ni(OH)2
12hr

Ni(OH)2
24hr

Figure 5. Fluorescence microscopy images of mitochondria membrane potential after
exposure to NiO or Ni(OH)2 for 12h or 24h.
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Figure 6. Measurement of Caspase-3 activity after exposure of NiO or Ni(OH)2 to A549
cells at 10, 25, 50, 75, and 100 µg/mL relative to the control. *p<0.05 vs. % of control
using a one-way t-test. **p<0.01. N=3.

Exposure to 100 µg/mL of Ni(OH)2 increased caspase-3 enzymatic activity by 1.7 and
2.1 times 24h and 48h, respectively.
3.3.4. Cell Death – Apoptosis. Apoptosis was measured to determine the role of
programed cell death in viability in A549 cells upon NiO or Ni(OH)2 exposure (Fig. 7).
For our purpose, the total apoptotic percentage of each population was the summation of
the subpopulation of cells undergoing early apoptosis and late apoptosis. Exposure to
NiO significantly increased the percentage of cells undergoing apoptosis at 50, 75,
and100 μg/mL at 24h, reaching up to 9.8% (N=4, p<0.05). Exposure to NiO significantly
increased the percentage of cells undergoing apoptosis at 25 and 100 μg/mL at 48h (N=4,
p<0.05). Interestingly, the rate of apoptosis decreased from 10.6% (at 25 μg/mL) to 7.3%
(at 50 μg/mL) and 6.4 (at 75 µg/mL) before once again increasing to 9.8% (at 100
μg/mL). Exposure to Ni(OH)2 significantly increased the percentage of cells undergoing
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Figure 7. Flow cytometer analysis of apoptosis in A549 cells after exposure to NiO or
Ni(OH)2 for 24 or 48 hours. *p < 0.05 compared to each respective control using a oneway ANOVA with a Dunnett comparison.

apoptosis at 25 μg/mL and above at 24h and at 50 μg/mL and above at 48h (N=4,
p<0.05). Apoptotic percentages reached up to 8.5% and 14.7% for 24h and 48h Ni(OH)2
exposure, respectively.

3.4. ALTERATION OF CELL CYCLE LEADS TO A SUPRESSION OF
PROLIFERATION
3.4.1. Alteration of Cell Cycle. The alteration of cell cycle was measured in
A549 cells upon exposure to NiO or Ni(OH)2 to determine whether cells become arrested
in various phases of the cell cycle. Cells can become arrested in any phase of the cell
cycle depending on various regulatory factors. Exposure to NiO and Ni(OH)2 resulted in
different changes in the cell cycle (Fig. 8). Cells were arrested in the S phase upon 24h
NiO exposure while cells became arrested in the S and G2/M phase upon 24h Ni(OH)2
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exposure. After 24h, cells in the S phase increased by 6.9% and 5.1% Upon NiO and
Ni(OH)2 exposure, respectively. The percentage of cells in the G2/M phase decreased
upon 24h NiO exposure by 2.6% and increased upon 24h Ni(OH)2 exposure by 2.4%.
After 48h, cells in the S phase increased by 2.3% and 4.5% Upon NiO and Ni(OH)2
exposure, respectively. The percentage of cells in the G2/M phase decreased upon 24h
NiO exposure by 2.2% and increased upon 24h Ni(OH)2 exposure by 11.5%.
3.4.2. Suppression of Cellular Proliferation. Proliferation was measured to
determine its role in cellular viability in A549 Comparisons in inhibition of proliferation
are hard to determine from the cell cycle results because the cells became arrested in
different phases (Fig. 9). Exposure to NiO or Ni(OH)2 significantly reduced the rate of
proliferation at all tested concentrations at both time points (N=4, p<0.05). A steady
decrease in proliferation was seen at each increasing concentration of NP at 24h. NiO and
Ni(OH)2 reduced proliferation to 46.1% and 27.1%, respectively at the highest tested
concentration (100 µg/mL). There was as strong positive linear relationship between
viability and proliferation for NiO (R2 = 0.97) and Ni(OH)2 (R2 = 0.96) at 24h (Appendix
A5). Increasing concentrations of NiO resulted in a steady decrease in proliferation at
48h, dropping the proliferation rate to 21.6% at 100 µg/mL. Ni(OH)2 exposure at 48h
produced a steep decrease in proliferation between 25 µg/mL and 50 µg/mL.
Proliferation rates dropped from 47.2% (at 25 µg/mL) to 13.7% (at 50 µg/mL) and
ultimately down to 4.4% (at 100 µg/mL). There was as strong positive linear
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Figure 8. Flow cytometer analysis of cell cycle of A549 cells. Analysis was measured
after exposure to (A) 24h NiO (B) 24h Ni(OH)2, (C) 48h NiO (D) 48h Ni(OH)2.

relationship between viability and proliferation for NiO (R2 = 0.92) and Ni(OH)2 (R2 =
0.98) at 48h (Appendix A5).

4. DISCUSSION

In this study, we investigated the comparative cytotoxicity of two nickel NPs and
explored several cellular responses as components of cytotoxicity. We hypothesized that
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1) cytotoxicity of NiO and Ni(OH)2 NPs is cell line-, particle-, time-, and dosedependent, 2) cytotoxicity is mediated by oxidative stress and subsequent cellular events

Table 2. Changes in percentage of cells in various phases of the cell cycle upon exposure
to NiO or Ni(OH)2 for 24h or 48h.
G0/G1

S

G2/M

-2.9

+6.9

-2.6

-7.7

+5.1

+2.4

48h NiO

0

+2.3

-2.2

48h Ni(OH)2

-17

+5.4

+11.5

24h NiO
24h Ni(OH)2

including modulation of mitochondrial membrane potential and caspase-3 enzyme
activity, and 3) exposure to NiO and Ni(OH)2 NPs alters cell cycle leading to
suppression of cell proliferation. Cell viability assays revealed that cytotoxicity is cell
line-dependent. A549 cells (a lung cell line) are much more sensitive to NPs than HepG2
cells (a liver cell line). As A549 cells are epithelial cells in a respiratory organ, it is
presumably to be more sensitive to particle exposure than hepatic cells. Other studies are
in agreement with this notion. For instance, A549 cells experienced greater induction of
OS and lactate dehydrogenase (LDH) leakage, reduction in glutathione (GSH) levels,
dissipation of MMP, elevation of apoptotic gene expression, and decline in cellular
viability than HepG2 cells upon exposure to CuFe2O4 and ZnFe2O4 NPs [30, 31]. Upon
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exposure to a variety of sizes and concentrations of silica NPs, HepG2 cells are less
susceptible than A549 to toxic responses, including ROS induction, decline in GSH, and

Figure 9. Inhibition of proliferation of A549 cells upon exposure to NiO or Ni(OH)2.
*p<0.05 vs. control using a one-way t-test. **p<0.01. ***p<.0001. N=4.

reduction of cell viability [32]. A549 cells experienced a greater reduction in MMP and
reduction of viability than HepG2 cells upon silver NP exposure [33]. Another possible
explanation regarding the discrepancy of in vitro toxic response may be due to the fact
that the liver has a higher capacity of detoxifying functions (i.e., phase I & II enzymes)
than the lung. In vivo comparisons may also need to consider translocation of NPs from
the lung to the liver [34, 35].
We found that NiO and Ni(OH)2-induced cytotoxicity is concentration-, time-,
and particle-specific in A549 cells. A549 cells experienced concentration-dependent
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viability in all tested concentrations. Our studies were in agreement with other studies,
who further demonstrated that BEAS-2B cells are 1.5-fold more sensitive than A549 to
NiO [20, 21, 36]. While there are no studies of Ni(OH)2 toxicity in human cells, one
study did find concentration-dependent viability of Ni(OH)2 in the modified CHO-K1
cell line AS52 [28]. Our data revealed time- and particle- dependent cell viability of NiO
and Ni(OH)2 in A549 cells. Previous studies also found particle-dependent toxicity
between different nickel NPs. NiO NPs were found to induce more DNA damage than Ni
metal NPs in A549 cells [37]. The LC50 of NiOH is more than 6 times higher than that of
black NiO in the modified Chinese Hamster Ovary cell AS52 [28]. Further studies are
needed to determine the reason behind particle-dependent toxicity.
Our concentration- and time-dependent studies revealed dynamic changes in OSinduced cellular injuries as well as alteration of cell cycle leading to various degrees of
suppression of cell proliferation. OS was elevated upon exposure to NiO and Ni(OH)2
and had a strong correlation with cell viability at both time points. This informs that the
generation of free radicals and oxidants is a hallmark of NP toxicity that triggers
consequential molecular events leading to cell death. OS-mediated dissipation of MMP
due to exposure to both NPs was supported by apparent reduction in influx of cationic
JC-1 into mitochondria. Reduction of the number of healthy mitochondria in a cell might
play a consequential role in perturbing homeostasis of bioenergetics and multiple
signaling pathways pertaining to cell survival. One such signaling alteration is caspase-3
enzymatic activity and subsequent apoptosis. In general, our data indicates both NiO and
Ni(OH)2 elevates apoptosis in a time- and concentration-dependent manner, although the
trend is atypical. A review on literature revealed the complexity of NP-induced cell
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death. NiO-induced apoptosis in A549 cells did not elevate in a concentration-dependent
manner similar to the trend seen in our 48h NiO apoptosis results [21]. This study also
measured necrosis and found a consistent concentration-dependent increase. Another
study found that Mn2O3-induced apoptosis in A549 cells increased in various increments
[29]. The apoptotic rate would stay relatively the same between two concentrations
before drastically increasing in a subsequent concentration. By contrast, PVP-coated Ag
and Ag+ NPs induced both apoptosis and necrosis in time- and particle-dependent
manners in THP-1 monocyte cells [38]. The roles of apoptosis and necrosis are dynamic
in the context of acute response and prolonged exposure.
The degree of cell viability imposed by exposure to NPs is a function of cell death
and cell proliferation. As cell death induced by NPs has been demonstrated by a wealth of
literature, suppression of cell proliferation is relatively under-studied. Our tritiated
thymidine incorporation indicates a very strong linear correlation between cell viability
and proliferation for NiO and Ni(OH)2 over a period of 48h. These correlations indicate
that suppression of proliferation is a key factor in determining reduction of cell viability.
Modulation of cell proliferation has multiple causations. Alteration of cell cycle is one of
them. Our results showed that NiO arrests A549 cells in the S phase while Ni(OH)2
arrests cells in the S and G2/M phase. Previous studies have also found NP-mediated,
phase-specific alteration of cell cycle. Exposure to TiO2 caused HaCat cells to arrest in
the S phase while ZnO and CuO exposure caused G2/M arrest [39-41]. NPs composed of
the same elements but have different properties can also influence phase-specific arrest.
TiO2 arrested cells in the G2/M phase while arresting cells in the G0/G1 phase [42-44].
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Mechanisms of action that dictate particle- and phase-specific cell cycle alteration remain
unclear.

5. CONCLUSION

We have demonstrated that toxicity exerts by NiO and Ni(OH)2 NPs is cell lineconcentration-, time-, and particle-dependent in the range of 10-100 µg/mL. Ni(OH)2 is
more cytotoxic than NiO. NP-induced oxidative stress triggered subsequent dissipation of
mitochondrial membrane potential and induction of caspase-3 enzyme activity. The
subsequent apoptotic events lead to reduction in cell number, though the contribution of
necrosis to cell viability is unknown. In addition to cell death, suppression of cell
proliferation contributes to plays an essential role in regulating cell number. Elevated OS
had a strong correlation with viability. Collectively, the observed cell viability is a
function of cell death and suppression of proliferation (Fig. 10)
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Figure 10. Cell viability is a function of cell death and suppression of proliferation.
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APPENDIX

ADDITIONAL FIGURES AND TABLES FROM PAPER II

Table A1. Number of cells used in each type of experiment.
Experiment
Plate used
Cells Seeded
Cells Seeded
(24h)
(48h)
SRB (A549), Proliferation, 24 well plate
45,000
22,000
Caspase-3
SRB(HepG2)
24 well plate
120,000
120,000
Cell cycle, Apoptosis
6 cm plate
250,000
120,000
ROS
96 well plate
1,500
750
MMP
35 mm microscope plate 15,000
---
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Figure A2. Linear correlation between viability and OS for (A) 24h NiO (B) 24h NiOH
(C) 48h NiO (D) 48h NiOH.
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Figure A3. Apoptosis graphs.
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Figure A4. Cell cycle.
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Figure A5. Linear correlation between viability and proliferation for (A) 24h NiO (B) 24h
NiOH (C) 48h NiO (D) 48h NiOH.
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2. CONCLUSION

Recent studies have begun assessing the safety of nanoparticles to insure human
and environmental health. Paper one explored some of the specific properties related to
nanoparticle toxicity and have found size, surface area, shape, particle charge, dissolution
rate, and available binding sites correlate with toxicity. The biochemical and molecular
mechanisms of cytotoxicity were then explored, with an emphasis on the mechanisms of
cell cycle alteration. Overall, viability is thought to be a function of the suppression of
proliferation and cell killing. Paper two explored the specific differential toxicity between
NiO and Ni(OH)2. Differences in viability upon nanoparticle exposure were found to be
cell line-, time-, concentration-, and particle-dependent. Various mechanisms responsible
for viability were investigated including induction of oxidative stress, dissipation of
mitochondrial membrane potential, and induction of caspase-3 enzymatic activity.
Alterations in cell cycle, changes in proliferation rate, and induction of apoptosis were
also delineated. In summary, cytotoxicity is mediated by oxidative stress-mediated cell
death and suppression of proliferation.
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